Address: Av. Francisco Matarazzo, 1500 – 13º andar – Ed. New York – Bairro Água Branca – São Paulo – SP,Brazil
Tel: (11) 3868.9100
Web: http://www.novonordisk.com.br/documents/home_page/document/index.asp
Novo Nordisk is a world leader in diabetes care. In addition, the company has a leading position in areas such as haemostasis management, growth hormone therapy and replacement therapy hormonal. Novo Nordisk manufactures and markets pharmaceutical products and services that make a significant difference to patients, physicians and society. With headquarters in Denmark, Novo Nordisk employs approximately 30,900 people in 79 countries and sells products in 179 countries.
Present in Brazil since 1990, Novo Nordisk has consolidated its presence in the country in 2002 when it bought the lab Biobrás – the only domestic producer of insulin. Reaffirming the company’s interest and commitment to the country in April 2007, Novo Nordisk launched the largest insulin plant in Latin America, in Montes Claros – MG, with investments of over U.S. $ 200 million.
During these two decades, the Brazilian affiliate has consolidated its presence in Diabetes, Hemophilia Growth Hormone and contributing to change the lives of patients around the country.
Diabetes, Haemophilia, Growth Hormone
Allan Finkel, recently voted Novo Nordisk’s best GM globally, speaks about the partnerships and projects that the Brazilian affiliate organizes with doctors and patient associations to increase diabetes awareness in…
Diabetes affects an estimated 6 million Brazilians, a figure which is expected to double by 2025, in line with many other developing nations. Like many other “rich-country” diseases, there is…
The latest from Brazilian Pharma, including the controversial proposal to transform Brazil’s regulatory agency, ANVISA; Ease Labs’s canabidiol approval, Biolab’s international expansion ambitions and Eurofarma’s multiple myeloma deal. ANVISA’s…
Sarah Aiosa oversees the entire Latin America region for MSD, where the global giant is looking to build on its 100-year legacy by better addressing the continent’s health inequities and…
Latin America is a rapidly growing market for the global medtech industry, offering significant opportunities. With a population of over 650 million people, the region boasts a large and growing…
Guilherme Marques, president of Siemens Healthineers LatAm, discusses the health tech giant’s regional strategy, covering how the firm rides out the region’s economic and political storms, its participation in disease…
Latin America is a crucial region for medtech market leader Medtronic. Home to 20,000 of the company’s 95,000+ global workforce, 12 manufacturing plants, and ten commercial organisations, Medtronic LatAm grew…
In 2019 the pharma industry financed some 700 clinical studies in Latin America with investments of more than USD one billion and according to FIFARMA, the leading association of innovators…
Renata Mihich, a 25-year DHL veteran, recently took on a new role as Head of LatAm for Italian healthcare logistics specialist BOMI GROUP. At a moment of career transformation, BOMI…
While regulatory agencies in several Latin American countries have made significant efforts to improve processes and accelerate approval times, a number of access hurdles still remain across the region. Here,…
Rolf Hoenger describes how Roche is driving access and awareness for innovative medicines in Latin America and weighs in on a number of important topics, from regulatory harmonisation in the…
After a successful international career, Andre Vivan da Silva recently returned to his native Brazil to become GSK’s country manager. He explains the importance of vaccination, in Brazil, and HIV…
Although Brazil is one of the world’s top pharma markets, with the highest market value in Latin America, and has made major strides towards universal healthcare, the country continues to…
Novo Nordisk’s Latin America lead Allan Finkel outlines the “alarming” burden of diabetes and obesity in his region, the progress that has been made via national campaigns against diabetes, and…
See our Cookie Privacy Policy Here
